GO
Loading...

Enter multiple symbols separated by commas

Johnson & Johnson

More

  • April 28- Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits. Boston Scientific said in February it would pay Johnson& Johnson $600 million to settle a long-running lawsuit over Boston Scientific's acquisition of rival Guidant in 2005..

  • April 28- U.S. drugmaker Pfizer Inc cut its full-year revenue and profit forecast, blaming a stronger dollar. Pfizer's shares were roughly unchanged at $34.62 in premarket trade on Tuesday morning. Pfizer's net profit rose to $2.38 billion, or 38 cents per share, in the latest quarter, from $2.33 billion, or 36 cents per share, a year earlier.

  • The 10 global companies that get diversity: Study Friday, 24 Apr 2015 | 11:03 AM ET

    These 10 companies lead the way when it comes to diversity as a cultural and business aim, according to an annual ranking from DiversityInc.

  • April 24- Advertising agency Interpublic Group of Cos Inc's quarterly revenue trumped expectations as higher ad spending by U.S. businesses made up for the strong dollar's impact on international revenue. Interpublic, whose clients include General Motors Co, Johnson& Johnson and L'Oréal, got about 60 percent of revenue from the United States in the first...

  • *Global nutraceutical market seen at $280 bln by 2018. LONDON, April 21- A boom in "nutraceuticals"- food and drinks with potential health benefits- is paving the way for a rush of deals, as food and drug companies compete to dominate a market expected to be worth $280 billion by 2018.. "The space is ripe for M&A and I think you are going to see more," added Jeremy Johnson,...

  • LONDON, April 16- Shares in French drugmaker Ipsen and its Swedish partner Active Biotech fell sharply on Thursday after the companies announced an experimental medicine had failed to extend lives for prostate cancer sufferers. Ipsen stock was down 10 percent in early trade while Active Biotech, which originally developed the drug, slumped 60 percent.

  • US industrial output falls on mining, utilities Wednesday, 15 Apr 2015 | 12:18 PM ET
    Welder Aluminum Case Company

    Industrial production recorded its biggest drop in more than 2-1/2 years, fresh evidence that economic growth slowed sharply in the first quarter.

  • WRAPUP 1-Mining, utilities sink U.S. industrial production Wednesday, 15 Apr 2015 | 11:05 AM ET

    WASHINGTON, April 15- U.S. industrial output posted its biggest drop in more than 2-1/ 2 years in March in part as oil and gas well drilling plummeted, highlighting the negative impact of lower crude prices and a strong dollar on the economy. An unusually snowy winter weighed on activity early in 2015. Labor disruptions at normally busy West Coast ports, as well as...

  • Cramer Remix: This company's worth double Tuesday, 14 Apr 2015 | 7:33 PM ET
    Jim Cramer on the set of Mad Money

    “Mad Money” host Jim Cramer’s revealing an undervalued play that may surprise you.

  • UPDATE 1-Aduro IPO pricing values drugmaker at $1 bln Tuesday, 14 Apr 2015 | 6:23 PM ET

    Aduro, which counts Johnson& Johnson and Swiss drugmaker Novartis AG among its investors, is selling all the 7 million shares in the offering. To gain access to Aduro's cancer immunotherapy technology, Novartis last month entered into a tie-up worth about $750 million with the company. Novartis Institutes for BioMedical Research Inc, an affiliate of Novartis,...

  • Cramer: Big market positives that can't be ignored Tuesday, 14 Apr 2015 | 6:12 PM ET
    A shopper touches the screen of an Apple Watch in New York.

    Jim Cramer gives a fresh dose of reality when he focuses investors on all of the positive inputs in the market right now.

  • April 14- Aduro Biotech Inc's initial public offering has been priced at $17 per share, an underwriter said, valuing the cancer immunotherapy drug developer at about $1 billion. Aduro, which counts Johnson& Johnson and Novartis AG among its investors, is selling all the 7 million shares in the offering. The company had previously planned to sell 5 million shares...

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed mixed on Tuesday as investors digested the first of the major earnings reports and moderate economic data.

  • Four trades to go before Tuesday's close Tuesday, 14 Apr 2015 | 3:19 PM ET

    The "Halftime Report" traders give their trades for the second half.

  • NEW YORK, April 14- The U.S. dollar tumbled on Tuesday, weighed down by mixed retail sales data and economic growth predictions, while crude rose after a surprise drop in forecasts for U.S. shale oil production. A lower full-year earnings forecast from Johnson& Johnson due to the impact of dollar strength kept gains in check. "Expectations are low, primarily because...

  • *Norfolk Southern gives weak outlook, shares fall. NEW YORK, April 14- The Dow and S&P 500 moved higher on Tuesday, helped by energy stocks and March-quarter earnings reports that topped modest expectations but did little to reduce concerns about the strong dollar. Norfolk Southern Corp was the biggest decliner on the S&P 500, dropping 5.6 percent to $98.95 a day...

  • WASHINGTON, April 14- U.S. retail sales rose in March for the first time since November as consumers stepped up purchases of automobiles and other goods, suggesting a sharp slowdown in economic growth in the first quarter was temporary. The Commerce Department's fairly sturdy report on Tuesday together with other data showing that producer inflation crept up...

  • NEW YORK, April 14- Crude prices rose on Tuesday after a surprise drop in expectations for U.S. shale oil production while the dollar fell and stocks edged lower with investors focused on U.S. corporate earnings and retail sales data. U.S. stocks were little changed as gains in banks JPMorgan and Wells Fargo were offset by a full-year earnings forecast downgrade...

  • *JPMorgan rises after results, Wells Fargo lower. *Norfolk Southern gives weak outlook, shares fall. Norfolk Southern Corp was the biggest decliner on the S&P 500, dropping 5.6 percent to $98.95 a day after it forecast a surprise drop in its first-quarter earnings and revenue.

  • Apple and IBM take on health care data with Watson Tuesday, 14 Apr 2015 | 10:47 AM ET
    Apple announces Healthkit for iOS 8.

    IBM is teaming with Apple, J&J and Medtronic in hopes of revolutionizing the health care industry.